2.50
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 2.50
loading
Precedente Chiudi:
$2.50
Aprire:
$2.47
Volume 24 ore:
116.62K
Relative Volume:
0.09
Capitalizzazione di mercato:
$56.19M
Reddito:
-
Utile/perdita netta:
$-55.99M
Rapporto P/E:
-0.9995
EPS:
-2.5013
Flusso di cassa netto:
$-47.60M
1 W Prestazione:
+0.00%
1M Prestazione:
+76.06%
6M Prestazione:
+95.31%
1 anno Prestazione:
+129.36%
Intervallo 1D:
Value
$2.44
$2.50
Intervallo di 1 settimana:
Value
$2.44
$2.60
Portata 52W:
Value
$0.9612
$2.79

Boundless Bio Inc Stock (BOLD) Company Profile

Name
Nome
Boundless Bio Inc
Name
Telefono
(858) 766-9912
Name
Indirizzo
10955 ALEXANDRIA WAY, SAN DIEGO
Name
Dipendente
28
Name
Cinguettio
Name
Prossima data di guadagno
2026-08-04
Name
Ultimi documenti SEC
Name
BOLD's Discussions on Twitter

Compare BOLD vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
BOLD icon
BOLD
Boundless Bio Inc
2.50 56.19M 0 -55.99M -47.60M -2.5013
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
522.25 134.41B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
676.23 68.13B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
919.94 57.01B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
321.59 41.79B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
190.46 40.39B 742.00K -1.37B -1.07B -7.0731

Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-02 Iniziato H.C. Wainwright Buy
2025-05-28 Downgrade Leerink Partners Outperform → Market Perform
2024-12-13 Downgrade Guggenheim Buy → Neutral
2024-04-22 Iniziato Guggenheim Buy
2024-04-22 Iniziato Leerink Partners Outperform
2024-04-22 Iniziato Piper Sandler Overweight
Mostra tutto

Boundless Bio Inc Borsa (BOLD) Ultime notizie

pulisher
Jul 06, 2026

Boundless Bio to merge with Serapha Bio in reverse merger; shares surge - MSN

Jul 06, 2026
pulisher
Jul 06, 2026

Boundless Bio ten percent owner Kristina Burow sells $39,840 in stock - Investing.com

Jul 06, 2026
pulisher
Jul 06, 2026

Arch venture funds sell $39,840 in Boundless Bio stock - Investing.com

Jul 06, 2026
pulisher
Jul 06, 2026

Form 4 Boundless Bio Inc For: 6 July By Investing.com - Investing.com Canada

Jul 06, 2026
pulisher
Jul 06, 2026

ARCH funds, insiders trade 16,000 Boundless Bio (BOLD) shares - Stock Titan

Jul 06, 2026
pulisher
Jul 06, 2026

16K Boundless Bio (BOLD) shares sold by ARCH funds post-exercise - Stock Titan

Jul 06, 2026
pulisher
Jul 06, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jul 06, 2026
pulisher
Jul 03, 2026

TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Boundless Bio Inc - GuruFocus

Jul 03, 2026
pulisher
Jul 02, 2026

Major Investor Doubles Down on Boundless Bio With Bold New Stock Purchase - TipRanks

Jul 02, 2026
pulisher
Jul 02, 2026

Kevin Tang buys $268,880 of Boundless Bio (NASDAQ:BOLD) shares - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

Form 4 Boundless Bio Inc For: 2 July By Investing.com - Investing.com UK

Jul 02, 2026
pulisher
Jul 02, 2026

Boundless Bio (BOLD) major holder buys 107,463 Common shares - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS - Sahm

Jul 02, 2026
pulisher
Jun 29, 2026

Major Investor Makes Bold Move on Boundless Bio Shares - TipRanks

Jun 29, 2026
pulisher
Jun 29, 2026

Tang Capital Management acquires $714,768 of Boundless Bio stock - Investing.com

Jun 29, 2026
pulisher
Jun 29, 2026

Tang Capital Management acquires $714,768 of Boundless Bio stock By Investing.com - Investing.com Nigeria

Jun 29, 2026
pulisher
Jun 29, 2026

Form 4 Boundless Bio Inc For: 29 June By Investing.com - Investing.com India

Jun 29, 2026
pulisher
Jun 29, 2026

Tang-linked entities report 11.3% stake in Boundless Bio (NASDAQ: BOLD) - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Tang Capital-affiliated funds boost Boundless Bio (BOLD) stake with 286K-share buy - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Tang Capital entities disclose 2.25M Boundless Bio (BOLD) shares in Form 3 filing - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Enterprise value to revenue forward of Boundless Bio, Inc. – NASDAQ:BOLD - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Enterprise value to EBITDA forward of Boundless Bio, Inc. – NASDAQ:BOLD - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Price to sales forward of Boundless Bio, Inc. – NASDAQ:BOLD - TradingView

Jun 29, 2026
pulisher
Jun 26, 2026

Boundless Bio Inc. Actuals & Estimates (NASDAQ:BOLD) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

BOLD Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

Crude Oil Down Over 1%; US Manufacturing PMI Surges In June - Sahm

Jun 24, 2026
pulisher
Jun 24, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Sahm

Jun 24, 2026
pulisher
Jun 24, 2026

Dow Falls Over 300 Points; Korn Ferry Earnings Top Views - Sahm

Jun 24, 2026
pulisher
Jun 23, 2026

NewCo Serapha taking path to NASDAQ via merger with Boundless: Deals Report - biocentury.com

Jun 23, 2026
pulisher
Jun 23, 2026

$Boundless Bio (BOLD.US)$ - Moomoo

Jun 23, 2026
pulisher
Jun 23, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD) - PR Newswire

Jun 23, 2026
pulisher
Jun 23, 2026

Serapha Bio takes flight from Boundless merger with $230M and gene-editing prospect from China - Fierce Biotech

Jun 23, 2026
pulisher
Jun 23, 2026

Form 8K Boundless Bio Inc For: 23 June By Investing.com - Investing.com South Africa

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio and Serapha Bio to merge - The Pharma Letter

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio's reverse merger; CARsgen wins first solid tumor approval for CAR-T - Endpoints News

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio Inc. (BOLD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jun 23, 2026
pulisher
Jun 23, 2026

The market is filled with gapping stocks in Tuesday's session. - ChartMill

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio to Merge with Serapha Bio, Restructure Operations - TipRanks

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD Stock Pops As Traders Target Volatile Bounce - StocksToTrade

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD: All-stock merger creates a focused gene editing company targeting AATD with strong financial runway - TradingView

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD: All-stock merger creates a gene-editing leader targeting AATD, with Boundless shareholders receiving a cash dividend - TradingView

Jun 23, 2026
pulisher
Jun 23, 2026

US market outlook: Semiconductors and large-cap stocks decline amid concerns over US rate hikes and rising procurement costs; SoFi acquires Composer to bolster AI-driven trading; Boundless Bio shares surge on merger announcement with Seraffa - Moomoo

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD Stock Grinds Sideways As Traders Eye Cash Runway - timothysykes.com

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio stock surges on Serapha Bio merger agreement By Investing.com - Investing.com Australia

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio stock surges on Serapha Bio merger agreement - Investing.com

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio (BOLD) to merge with Serapha after $230M+ financings; 75% workforce cut - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Serapha Bio to take control of Boundless Bio (NASDAQ: BOLD) in cash-dividend merger - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

What's going on in today's pre-market session - ChartMill

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio Agrees To Merge With Serapha Bio - Finimize

Jun 23, 2026

Boundless Bio Inc Azioni (BOLD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Boundless Bio Inc Azioni (BOLD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
CRANDELL KEITH
10% Owner
Jul 01 '26
Sale
2.49
16,000
39,840
0
ARCH Venture Fund IX, L.P.
10% Owner
Jul 01 '26
Option Exercise
1.03
16,000
16,480
16,000
ARCH Venture Fund IX, L.P.
10% Owner
Jul 01 '26
Sale
2.49
16,000
39,840
0
TANG KEVIN
10% Owner
Jul 01 '26
Buy
2.49
71,612
178,314
2,631,487
TANG KEVIN
10% Owner
Jun 30 '26
Buy
2.54
26,030
66,112
2,559,875
TANG KEVIN
10% Owner
Jul 02 '26
Buy
2.49
9,821
24,454
2,641,308
$112.84
price up icon 1.17%
$57.80
price up icon 1.55%
$36.31
price up icon 2.60%
$79.77
price down icon 2.48%
ONC ONC
$308.96
price down icon 0.16%
$190.46
price up icon 0.25%
Capitalizzazione:     |  Volume (24 ore):